Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Regeneron Pharmaceuticals Inc
SWB:RGO
Regeneron Pharmaceuticals Inc
SWB:RGO
Price:
129.11
EUR
0.26%
Market Closed
Market Cap:
€13.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Regeneron Pharmaceuticals Inc
SWB:RGO
|
US |
|
Acanthe Developpement SE
F:ADX
|
FR |
Wall St Price Targets
RGO Price Forecast
Based on 32 analysts
Based on 32 analysts
-5% Downside
from
€129.11
today
Regeneron Pharmaceuticals Inc (RGO)’s 12-month stock price forecast through January 2014 has a consensus target of €123.2, implying 5% downside. The forecast is based on price targets from 32 Wall Street analysts.
RGO Analyst Rating
No ratings yet
No ratings yet
Regeneron Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
123.2
EUR
123.2
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 123.2 EUR with a low forecast of 103.94 EUR and a high forecast of 151.02 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 8 years is 11%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
19%
19%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 22%. The projected CAGR for the next 3 years is 19%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 8 years is 8%.